Liposomal CoQ10 is a next-generation delivery format in which Coenzyme Q10 — a naturally synthesised, fat-soluble compound present in virtually every cell of the human body — is enclosed within a phospholipid vesicle structure. This encapsulation strategy directly addresses the most significant limitation of conventional CoQ10 supplementation: its extremely poor aqueous solubility and correspondingly low oral bioavailability.
CoQ10 occupies a critical role in cellular energy metabolism, functioning as an indispensable electron carrier within the mitochondrial respiratory chain. It also serves as one of the body's most potent endogenous antioxidants, working to neutralise reactive oxygen species that contribute to cellular ageing and oxidative tissue damage. The challenge has always been getting adequate amounts of this compound to where it is needed most — the mitochondria within target cells.
The phospholipid bilayer of the liposome shares a structural resemblance with the body's own cellular membranes. This biological similarity enables the liposome to fuse directly with cell walls, bypassing conventional absorption barriers and delivering its payload into the intracellular environment with high efficiency. In its final manufactured form, Liposomal CoQ10 typically presents as a yellow to orange-yellow powder with excellent dispersibility in aqueous systems.
This advanced formulation approach yields a compound capable of supporting cardiovascular function, sustaining mitochondrial ATP production, and providing robust antioxidant defence — with a pharmacokinetic profile that is meaningfully superior to that of standard ubiquinone or ubiquinol preparations.